The Time Has Come for This Small Biotech Firm to Grow and Thrive
April 30, 2020
0
CytomX Therapeutics CytomX (CTMX) is a clinical-stage oncology-focused biopharmaceutical company developing a novel class of investigational antibody therapeutics based on the firm’s Probody® technology platform for cancer treatments. CytomX’s Probody therapeutics remain inactive until they are activated by proteases in the tumor microenvironment. Why This is Important By . . . This content is for paid subscribers. Please click here to subscribe or here to log in.